Co-Authors
This is a "connection" page, showing publications co-authored by Joseph Gligorov and Philippe Maingon.
Connection Strength
0.118
-
High seroconversion rate but low antibody titers after two injections of BNT162b2 (Pfizer-BioNTech) vaccine in patients treated with chemotherapy for solid cancers. Ann Oncol. 2021 10; 32(10):1294-1295.
Score: 0.060
-
Weak immunogenicity after a single dose of SARS-CoV-2 mRNA vaccine in treated cancer patients. Ann Oncol. 2021 08; 32(8):1051-1053.
Score: 0.059